C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/4439 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2682859
The present invention relates to crystalline polymorphic and amorphous form of 6- [2- (methylcarbamoyl) phenyl sulfanyl] -3-E- [2- (pyridin-2- yl) ethenyl] indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic form and to the therapeutic or prophylactic use of such polymorphic forms and compositions.
La présente invention concerne une nouvelle forme cristalline polymorphe et amorphe de 6-[2-(méthyIcarbamoyl)phénylsulfanyl]-3-E-[2-(pyridin-2- yl)éthényl]indazole, et les procédés d'élaboration correspondant. L'invention concerne également des compositions pharmaceutiques contenant au moins une forme polymorphe et l'utilisation thérapeutique ou prophylactique de telles formes polymorphes et compositions.
Campeta Anthony Michael
Chekal Brian Patrick
Mclaughlin Robert William
Singer Robert Alan
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Novel crystalline forms of a vegf-r inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel crystalline forms of a vegf-r inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel crystalline forms of a vegf-r inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1632258